Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Induced sputum in the management of COPD: clinical implications.

Zanini A, Della Patrona S, Facchini AL, Spanevello A.

Monaldi Arch Chest Dis. 2012 Mar;77(1):23-5.

2.

Value of sputum differential count in chronic obstructive airway disease.

Neopane A, Sharma L, Dulal S, Panta S.

J Nepal Health Res Counc. 2013 Jan;11(23):26-9.

PMID:
23787521
3.

Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.

Brightling CE, Bleecker ER, Panettieri RA Jr, Bafadhel M, She D, Ward CK, Xu X, Birrell C, van der Merwe R.

Lancet Respir Med. 2014 Nov;2(11):891-901. doi: 10.1016/S2213-2600(14)70187-0. Epub 2014 Sep 7.

PMID:
25208464
4.

Bronchial hyperresponsiveness, airway inflammation, and reversibility in patients with chronic obstructive pulmonary disease.

Zanini A, Cherubino F, Zampogna E, Croce S, Pignatti P, Spanevello A.

Int J Chron Obstruct Pulmon Dis. 2015 Jun 17;10:1155-61. doi: 10.2147/COPD.S80992. eCollection 2015.

5.

The safety of sputum induction in adults with acute exacerbation of COPD.

Gao P, Gibson PG, Zhang J, He X, Hao Y, Li P, Liu H.

Clin Respir J. 2013 Jan;7(1):101-9. doi: 10.1111/j.1752-699X.2012.00291.x. Epub 2012 Apr 23.

PMID:
22452898
6.

[Value of sputum analysis in the management of inflammatory airway diseases].

Mazzei JA, Rocher AE, Palaoro L.

Medicina (B Aires). 2012;72(4):332-8. Review. Spanish.

7.
8.

Airway inflammation and cellular stress in noneosinophilic atopic asthma.

Tsoumakidou M, Papadopouli E, Tzanakis N, Siafakas NM.

Chest. 2006 May;129(5):1194-202.

PMID:
16685009
9.

Predicting sputum eosinophilia in exacerbations of COPD using exhaled nitric oxide.

Soter S, Barta I, Antus B.

Inflammation. 2013 Oct;36(5):1178-85. doi: 10.1007/s10753-013-9653-8.

PMID:
23681903
10.

Clinical characteristics and airway inflammation profile of COPD persistent sputum producers.

Khurana S, Ravi A, Sutula J, Milone R, Williamson R, Plumb J, Vestbo J, Singh D.

Respir Med. 2014 Dec;108(12):1761-70.

PMID:
25459449
12.

High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls.

Hou C, Zhao H, Liu L, Li W, Zhou X, Lv Y, Shen X, Liang Z, Cai S, Zou F.

Mol Med. 2011;17(7-8):807-15. doi: 10.2119/molmed.2010.00173. Epub 2011 Mar 3.

13.
14.

Airway inflammation and mannitol challenge test in COPD.

de Nijs SB, Fens N, Lutter R, Dijkers E, Krouwels FH, Smids-Dierdorp BS, van Steenwijk RP, Sterk PJ.

Respir Res. 2011 Jan 18;12:11. doi: 10.1186/1465-9921-12-11.

15.

Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.

Tufvesson E, Bjermer L, Ekberg M.

Int J Chron Obstruct Pulmon Dis. 2015 May 4;10:881-9. doi: 10.2147/COPD.S78748. eCollection 2015.

16.

Analysis of sputum cell counts during spontaneous moderate exacerbations of asthma in comparison to the stable phase.

Di Franco A, Bartoli ML, Carnevali S, Cianchetti S, Bacci E, Dente FL, Giannini D, Taccola M, Vagaggini B, Paggiaro PL.

J Asthma. 2003 Apr;40(2):155-62.

PMID:
12765317
17.

Changes in sputum composition during 15 min of sputum induction in healthy subjects and patients with asthma and chronic obstructive pulmonary disease.

Toungoussova O, Migliori GB, Foschino Barbaro MP, Esposito LM, Dragonieri S, Carpagnano GE, Salerno FG, Neri M, Spanevello A.

Respir Med. 2007 Jul;101(7):1543-8. Epub 2007 Jan 26.

18.

Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.

Brightling CE, McKenna S, Hargadon B, Birring S, Green R, Siva R, Berry M, Parker D, Monteiro W, Pavord ID, Bradding P.

Thorax. 2005 Mar;60(3):193-8.

19.

Airway inflammation in COPD: physiological outcome measures and induced sputum.

Crapo RO, Jensen RL, Hargreave FE.

Eur Respir J Suppl. 2003 Jun;41:19s-28s. Review.

20.

Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive study.

Birring SS, Brightling CE, Bradding P, Entwisle JJ, Vara DD, Grigg J, Wardlaw AJ, Pavord ID.

Am J Respir Crit Care Med. 2002 Oct 15;166(8):1078-83.

PMID:
12379551
Items per page

Supplemental Content

Write to the Help Desk